Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The activity of a specific rat enzyme in the prostate and epididymis is highly dependent on the acidity level.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Finasteride harms Daphnia magna's reproduction and metabolism.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride reduces movement issues in Parkinson's disease rats.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

Finasteride effectively treats hair loss and prostate issues by blocking a specific enzyme.

Some dibenzo compounds might help treat cancer with fewer side effects.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

A new method efficiently modifies alkenes to create useful medicinal compounds.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

MK-386 lowers DHT in blood and skin but not in semen.

Mitoquinone protects heart cells from doxorubicin damage and slightly boosts its effect on prostate cancer cells.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Finasteride is made through a series of chemical reactions starting from a specific intermediate compound.

PM-9 and finasteride effectively inhibit the enzyme that converts testosterone to DHT.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.